Skip to main content

Integral Ad Science Holding Corp(IAS-Q)
NASDAQ

Today's Change
Delayed Last Update
Day Low10.25
Day High10.34
Open:10.26
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

TOP STORIES: Integral Ad Science Holding Corp

Select a category then submit the form to load news
Tipranks
Integral Ad Science Completes Novacap Buyout, Goes Private
StockStory
3 Small-Cap Stocks That Fall Short
SBGI
StockStory
3 Profitable Stocks We Approach with Caution
TSCO
StockStory
Integral Ad Science (IAS): Buy, Sell, or Hold Post Q3 Earnings?
IAS
Baystreet
IAS Trumpets “Agent” to Aid Ad Campaigns
Tipranks
Integral Ad Science Files SEC Statement for Merger
StockStory
3 Growth Stocks We Steer Clear Of
IP
Motley Fool
Investor Cuts $12.9 Million Stake as IAS Heads Toward $1.9 Billion Buyout
StockStory
Advertising Software Stocks Q3 Highlights: Integral Ad Science (NASDAQ:IAS)
IAS
Motley Fool
Integral Ad Science (IAS) Earnings Transcript
StockStory
3 Stocks Under $50 Walking a Fine Line
KRUS
Tipranks
Integral Ad Science Reports Strong Q3 2025 Results
StockStory
1 Russell 2000 Stock with Exciting Potential and 2 We Question
APOG
StockStory
1 Software Stock on Our Watchlist and 2 We Ignore
UPST
Tipranks
Truist Financial Sticks to Its Hold Rating for Integral Ad Science (IAS)
StockStory
Integral Ad Science (NASDAQ:IAS) Delivers Impressive Q3
IAS
StockStory
3 Volatile Stocks with Questionable Fundamentals
TNL
StockStory
1 Small-Cap Stock with Competitive Advantages and 2 We Question
FRSH
StockStory
1 Unpopular Stock That Deserves a Second Chance and 2 Facing Challenges
MTW
StockStory
3 Cash-Producing Stocks That Concern Us
CARG
StockStory
Unpacking Q2 Earnings: Integral Ad Science (NASDAQ:IAS) In The Context Of Other Advertising Software Stocks
IAS
Tipranks
Scotiabank Remains a Hold on Integral Ad Science (IAS)
Tipranks
Integral Ad Science Announces Merger with Igloo Group
SYNDTGAM
Private equity firm Novacap to acquire Integral Ad Science for $1.9-billion
Canada’s telecom and television complaints watchdog is once again urging providers to better inform their customers about its services, as it says just under one-third were fully compliant with requirements of the organization's public awareness plan last year. A person uses a cellphone in Ottawa, Monday, July 18, 2022. THE CANADIAN PRESS/Sean Kilpatrick
StockStory
Why Are Integral Ad Science (IAS) Shares Soaring Today
IAS
Tipranks
IAS Earnings Call: Strong Growth and Strategic Moves
Tipranks
Evercore ISI Reaffirms Their Buy Rating on Integral Ad Science (IAS)
Tipranks
Integral Ad Science (IAS) Receives a Rating Update from a Top Analyst
Tipranks
Craig-Hallum Sticks to Their Buy Rating for Integral Ad Science (IAS)
Tipranks
Truist Financial Sticks to Their Buy Rating for Integral Ad Science (IAS)
Tipranks
Benchmark Co. Sticks to Their Hold Rating for Integral Ad Science (IAS)
Tipranks
Integral Ad Science Reports Strong Q2 2025 Growth

Profile

Integral Ad Science Holding LLC operates as a digital advertising verification company. It operates principally in the United States, the United Kingdom, Germany, Italy, Spain, Sweden, Singapore, Australia, France, Japan, Canada, Hong Kong and Brazil. Integral Ad Science Holding LLC is based in New York.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.